| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 10/21/2008 | US7439235 Solid phase extraction; contacting with adsorption resin |
| 10/21/2008 | US7439234 Administering Product R to maintain and improve production of white blood cells and platelets and to reduce gastrointestinal toxicity |
| 10/21/2008 | US7439231 Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof |
| 10/21/2008 | US7439230 Extracellular domain of CTLA4, with (a) an alanine at position +29 substituted with tyrosine, leucine, tryptophan, or threonine, and (b) a leucine at position +104 substituted with glutamic acid; binds CD80 and/or CD86 with greater avidity; inhibiting graft versus host disease |
| 10/21/2008 | US7439229 Controlling the action of cytokines, particularly chemokines, by inhibiting their binding with receptors; used as immunogens for use as metazoan parasite vaccines; antiallergens; veterinary medicine |
| 10/21/2008 | US7439228 Bioactive peptides |
| 10/21/2008 | US7439227 Use of selected cyclosporins for the treatment of hepatitis C infection |
| 10/21/2008 | US7439226 Serine protease inhibitors |
| 10/21/2008 | US7439225 Culturing Rhodococcus; antitubercular agents; side effect reduction |
| 10/21/2008 | US7439224 Indications of mannan-binding lectin (MBL) in the treatment of immuno-compromised individuals |
| 10/21/2008 | US7439223 Nucleophosmin/B23-binding peptide to inhibit tumor growth and regulate transcriptional activity of p53 |
| 10/21/2008 | US7439222 Process and systems for peptide synthesis |
| 10/21/2008 | US7439063 Providing acute neuroprotection by contacting neuronal cells with erythropoietin or active fragment or analog thereof close to or subsequent to time of excitatory insult and contacting cells with insulin-like growth factor, thereby producing synergistic acute neuroprotective effect; Alzheimer's disease |
| 10/21/2008 | US7439049 Isolated polypeptide with glycosyl transferase enzymatic activity for producing dextrans with alpha (1 --> 2) sidechains, comprising at least one region for bonding to glucan and a catalytically active region situated beyond the region bonding to glucan; expression vectors; genetic engineering |
| 10/21/2008 | US7439041 Prion-specific peptide reagents |
| 10/21/2008 | US7439029 Human 9q polypeptides method |
| 10/21/2008 | US7438933 Maternal multi-nutrient against diabetes-related birth defects |
| 10/21/2008 | US7438920 Crystallizable mixture and complexed crystal of hepatitis C virus NS3 helicase and a single stranded deoxyuridine oligonucleotide having 6 to 12 nucleotides; for use in X-ray crystallography; binding pocket structure |
| 10/21/2008 | US7438917 Peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes |
| 10/21/2008 | US7438914 Composition and method for enhancing immune response |
| 10/21/2008 | US7438913 Administering polypeptide which binds to interleukins; skin disorders, antiallergens, aids |
| 10/21/2008 | US7438908 Antitumor agents |
| 10/21/2008 | US7438906 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 10/21/2008 | US7438905 administering a mixture of carriers and drugs that modulate signal transduction mediated by activation inducible lymphocyte immunomodulatory molecule (AILIM); immunosuppressants |
| 10/21/2008 | US7438904 High-activity mutants of butyrylcholinesterase for cocaine hydrolysis and method of generating the same |
| 10/21/2008 | US7438903 Fine particle sizes; nanostructure; in mixture with oil, water carriers, excipients; oral diseases; cognition activators; hypotensive agents; immunology diseases; blood disorders |
| 10/21/2008 | US7438902 treating diabetes mellitus; isolating a nestin-positive pancreatic stem cell from a pancreatic islet of a donor; transferring the stem cell into the patient, wherein it differentiates into an insulin-producing cell; across allogeneic or xenogeneic barriers and graft rejection does not occur |
| 10/21/2008 | US7438890 Binding peptides for carcinoembryonic antigen (CEA) |
| 10/21/2008 | CA2333648C Thermoprotected microparticle compositions and process for terminal steam sterilization thereof |
| 10/21/2008 | CA2301401C Determining the transforming capability of agents |
| 10/21/2008 | CA2247998C Fragments of cr1 and their use |
| 10/21/2008 | CA2230452C Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof |
| 10/21/2008 | CA2171334C Substituted thiazolo[3,2-a]azepine derivatives |
| 10/21/2008 | CA2166108C Insulin preparations for inhalation |
| 10/21/2008 | CA2162361C Antisense oligonucleotides which combat aberrant splicing and methods of using the same |
| 10/21/2008 | CA2042064C C-erbb-2 external domain:gp75 |
| 10/20/2008 | CA2629419A1 Dietary supplement for the compensation of nutritional deficiency |
| 10/18/2008 | CA2583716A1 Oral dosage formulations of protease resistant polypeptides |
| 10/16/2008 | WO2008124724A1 Raav vector compositions having tyrosine-modified capsid proteins and methods for use |
| 10/16/2008 | WO2008124698A2 Methods of use of gamma inhibitor compounds for the attenuation of pain |
| 10/16/2008 | WO2008124522A2 Amylin formulations |
| 10/16/2008 | WO2008124500A1 Lung volume reduction therapy using crosslinked biopolymers |
| 10/16/2008 | WO2008124406A2 Methods of treatment using glycopegylated g-csf |
| 10/16/2008 | WO2008124197A1 Imaging and therapy of virus-associated tumors |
| 10/16/2008 | WO2008124183A1 Methods of treating or preventing emesis using growth hormone secretagogues |
| 10/16/2008 | WO2008124176A2 Soluble and membrane-anchored forms of lassa virus subunit proteins |
| 10/16/2008 | WO2008124173A1 Combination therapy for cardiac revascularization and cardiac repair |
| 10/16/2008 | WO2008124172A1 Combination therapy for chronic dermal ulcers |
| 10/16/2008 | WO2008124166A2 Fusion proteins of collagen-binding domain and parathyroid hormone |
| 10/16/2008 | WO2008124126A1 Oxygen-generating compositions for enhancing cell and tissue survival in vivo |
| 10/16/2008 | WO2008123918A1 Cellular compositions for the treatment of kidney disease and uses thereof |
| 10/16/2008 | WO2008123625A1 Method for activating receptor by cofactor and method for utilizing ligand activity |
| 10/16/2008 | WO2008123308A1 Therapeutic agent comprising vasohibin |
| 10/16/2008 | WO2008123202A1 METHOD FOR INHIBITION OF SIGNALING THROUGH ErbB2, SIGNALING INHIBITOR FOR USE IN THE METHOD, AND USE OF THE SIGNALING INHIBITOR |
| 10/16/2008 | WO2008123128A1 Adiponectin production enhancer |
| 10/16/2008 | WO2008123096A1 Prophylactic agent for renal failure |
| 10/16/2008 | WO2008123095A1 Prophylactic agent for heart failure |
| 10/16/2008 | WO2008122687A1 Protein gp120 polypeptide capable of inhibiting the life cycle of the aids virus |
| 10/16/2008 | WO2008122440A2 Remedy for the treatment of cardio-vascular diseases or disorders |
| 10/16/2008 | WO2008122434A1 Bis-met histones |
| 10/16/2008 | WO2008122425A2 Oral compositions containing tacrolimus in amorphous form |
| 10/16/2008 | WO2008122294A1 Peptides, antibodies and fragments thereof for the treatment and diagnostic of celiac disease |
| 10/16/2008 | WO2008122118A1 Pharmaceutical formulations of ghrh molecules |
| 10/16/2008 | WO2008105911A3 Crystallized oxalate decarboxylase and methods of use |
| 10/16/2008 | WO2008101098A3 Use of botulinum toxin and enzymes for treating bladder or prostata disorders, or hyperhydrosis |
| 10/16/2008 | WO2008098212A3 Extended release formulations of glucagon and other peptides and proteins |
| 10/16/2008 | WO2008096268A3 Autologous lymph node transfer in combination with vegf-c or vegf-d growth factor therapy to treat secondary lymphedema and to improve reconstructive surgery |
| 10/16/2008 | WO2008089756A3 Method for assaying antibodies in body fluids by immune reaction with glycoprotein 2 (gp2) from zymogenic granules of the pancreas for the differential diagnosis of inflammatory intestinal diseases and chronic pancreatitis |
| 10/16/2008 | WO2008089394A3 Mycobacterium tuberculosis persistance genes |
| 10/16/2008 | WO2008088875A9 Method of treating hepatitis c virus |
| 10/16/2008 | WO2008088548A3 Disintegrin variants and pharmaceutical uses thereof |
| 10/16/2008 | WO2008086523A3 Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof |
| 10/16/2008 | WO2008086452A3 Treatment and prevention of alzheimer's disease |
| 10/16/2008 | WO2008083157A3 Altering pgc-1alapha, ampk, fiaf, or the gastrointestinal microbiota as a means to modulate body fat and/or weight loss in a subject |
| 10/16/2008 | WO2008080035A3 Randomly oriented, fgf-2- modified nanofiber device for use in spinal cord repair |
| 10/16/2008 | WO2008079270A3 Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis |
| 10/16/2008 | WO2008077027A3 Treatment of post-menopausal and post-hysterectomy mediated cognitive disorders |
| 10/16/2008 | WO2008076857A3 Method and compositions for inhibiting mage protein interaction with kap-1 |
| 10/16/2008 | WO2008070833A3 Use of sh2 stat3/stat1 peptidomimetices as anticancer drugs |
| 10/16/2008 | WO2008063493A3 Compositions and methods related to toll-like receptor-3 |
| 10/16/2008 | WO2008058547A3 Alpha-lactalbumin composition |
| 10/16/2008 | WO2008058125A3 Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs |
| 10/16/2008 | WO2008055059A3 Bi-functional peptides for multiple sclerosis treatment and diagnosis |
| 10/16/2008 | WO2008054561A3 Proteins, nucleic acids encoding the same and associated methods of use |
| 10/16/2008 | WO2008051477A3 Hcv ns3 protease inhibitors |
| 10/16/2008 | WO2008034093A3 HIGHLY FLUORINATED β-AMINO ACIDS AND METHODS OF MAKING AND USING SAME |
| 10/16/2008 | WO2008033888A3 Methods for administering long-lasting hypoglycemic agents |
| 10/16/2008 | WO2008033556A3 High pressure treatment of proteins for reduced immunogenicity |
| 10/16/2008 | WO2008027899A3 Methods and compositions related to apobec-1 expression |
| 10/16/2008 | WO2008024858A3 Methods and compounds regulating the erythroid response to iron deficiency |
| 10/16/2008 | WO2008024194A3 Method of conserving and preparing tissue or cells for transfer, transplant, re-implantation, further study or the like |
| 10/16/2008 | WO2008014240A3 Dimeric iap inhibitors |
| 10/16/2008 | WO2008013953A3 Tyrosine phosphorylation sites |
| 10/16/2008 | WO2008011234A3 Recombinant host for producing l-asparaginase ii |
| 10/16/2008 | WO2008009634A3 Factor viia analogues with increased activity for treating thrombocytopenia |
| 10/16/2008 | WO2008008772A3 Methods for treating and limiting fibrotic disorders and keloids |
| 10/16/2008 | WO2008001370A3 Caspase-8 and inflammation, infection and wound healing |
| 10/16/2008 | WO2007149141A3 C1-inactivator inhibits two-chain urokinase mutant and limits hemostatic bleeding during thromolysis |
| 10/16/2008 | WO2007146003A3 Methods for ester detoxication |
| 10/16/2008 | WO2007134813B1 Use of desmodus salivary plasminogen activator (dspa) for treating venous thromboembolism |